MarketPeel
Insider Trading Intelligence
EVP R&D, Chief Medical Officer
Wed, Apr 1, 2026
Apr 1
exercised or converted securities in ALKS
5,000 shares @ $0.00
Decreased holdings by -23.40%
Option Exercise
Sale tied to a same-time option exercise
ALKSAlkermes plc.
Health CarePharmaceuticals
1D0.00%
1W-1.49%
1M-8.62%
3M
6M
1Y

Recent insider activity at ALKS

FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback